Related Experiment Video

Updated: Sep 18, 2026

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
06:58

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

Rebound fever in bacterial meningitis: role of dexamethasone dosage

E Pichard1, D Gillis, M Aker

  • 1Department of Pediatrics, Hadassah University Hospital, Jerusalem, Israel.

Israel Journal of Medical Sciences
|May 1, 1994
PubMed

Insights

A 2-day course of dexamethasone in bacterial meningitis treatment may reduce fever duration and secondary fever cases. This approach could potentially decrease unnecessary medical evaluations and patient concern, warranting further investigation for neurological benefits.

Area of Science:

  • Infectious Diseases
  • Pediatrics
  • Pharmacology

Background:

  • Bacterial meningitis treatment often includes antibiotics and dexamethasone.
  • An increase in secondary fever cases has been observed with adjuvant dexamethasone therapy.
  • Secondary fever necessitates further investigation and can cause patient concern.

Purpose of the Study:

  • To analyze the incidence and characteristics of secondary fever in bacterial meningitis patients treated with dexamethasone.
  • To compare fever duration and outcomes between patients receiving different dexamethasone regimens and those receiving antibiotics only.
  • To evaluate the potential benefits of a shorter dexamethasone course in managing bacterial meningitis.

Main Methods:

  • Retrospective analysis of 19 consecutive bacterial meningitis cases over 5 years.
  • Categorization of patients into three groups: dexamethasone for 4 days, dexamethasone for 2 days, and antibiotics only.
  • Analysis of etiologic agents, fever duration, and occurrence of secondary fever.

Main Results:

  • Patients receiving dexamethasone had significantly shorter initial fever duration compared to those without (1.7 days vs. 5.3 days).
  • Secondary fever occurred in 9 of 11 patients on dexamethasone, but none in the antibiotic-only group.
  • A 2-day dexamethasone course resulted in low-grade, short-duration secondary fever (1 day), unlike the 4-day course.

Conclusions:

  • A 2-day dexamethasone regimen appears to be associated with a more benign fever course in bacterial meningitis.
  • The findings suggest a 2-day dexamethasone course may reduce costly evaluations for secondary fever.
  • Further research is needed to confirm the efficacy of a 2-day dexamethasone regimen in preventing neurological sequelae.

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Related Concept Videos

Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...